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INTRODUCTION 
Fowl cholera is an infectious disease of poultry and wild birds 
which is caused by a small Gram-negative bacterium, Pasteurella 
multoeida. The greatest mortality is usually observed in turkeys that 
are older than 16 weeks of age. £. multocida can produce either chronic 
or acute fowl cholera. In the chronic form, P^. multocida produces 
localized infections in wattles, sinuses, joints, and footpads. Chronic 
infections are seen more often in birds that have a reduced suscepti­
bility to P^. multocida. Occasionally, chronic infections can develop 
into acute infections. Most acute infections have a very rapid onset; 
as little as twelve hours may elapse between the appearance of symptoms 
and death. A very rapid and overwhelming septicemia develops, with 
symptoms being typical of endotoxin shock. Body temperature is elevated, 
nasal secretions become profuse and thickened, and petechial and 
ecchymotic hemmorhages often occur. Torticollis, cyanosis, diarrhea and 
anorexia are common. An acute infection may kill thousands of birds in 
a single day (1). The disease is believed to be spread between birds 
by excretions from the mouth that contaminate feed and drinking water 
(2). A number of wild and domestic animals can act as carriers of 
avian strains of P. multocida (3). 
Two procedures are used currently to vaccinate against fowl cholera: 
a live, low virulence strain, developed at Clemson University, can be 
used to vaccinate turkeys through their drinking water (4,5). 
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Alternatively, turkeys or chickens are vaccinated subcutaneously with 
formalin-killed P^. multocida suspended in Freund's incomplete adjuvant 
(6,7). Neither vaccine provides complete protection against the 
disease. 
In order to produce more effective vaccines against multocida 
infections of poultry, the immunologic responses to vaccination need 
to be characterized. Humoral and cell-mediated immunologic responses 
have not been completely defined. Certain areas are not well-under­
stood; particularly the role of complement, the relationship of 
resistance to antibody titer, the effector activity of T-lymphocytes, 
and phagocytosis. 
This dissertation reports on vaccine induced immunity to P^. 
multocida in chickens and turkeys. The principal objective of the 
research was to determine: (A) the protective role of antibodies, 
(B) whether in vitro and in vivo correlates of cell-mediated immunity 
could be demonstrated, (C) whether cell-mediated imune responses to P^. 
multocida vaccination were of similar magnitude as responses to 
Mycobacterium tuberculosis vaccination. Vaccine-induced immunity was 
studied by various methods, including passive protection, surgical 
bursectomy, drug induced immunosuppression, lymphocyte transformation, 
migration inhibition reaction, granuloma formation, and skin testing. 
In this research project, a formalin-inactivated multocida 
bacterin was used to vaccinate chickens and turkeys. The decision to 
use a killed bacterin instead of a live vaccine was based on a number of 
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salient observations. 
(A) Lymphocytes from turkeys that received formalin-inactivated 
adjuvanted bacterin underwent blast transformation after 
exposure to 2» multocida antigens (8,9). 
(B) Leukocyte migration inhibition was observed when formalin-
inactivated adjuvanted bacterin was used (10). 
(C) The Clemson University strain, a live vaccine, does not induce 
an immunity that is as effective or as durable as a formalin-
inactivated adjuvanted bacterin (9). 
(D) Live vaccines occasionally induce significant mortality 
(5,11). 
(E) Live attenuated P^. miiltocida vaccines are usually given through 
the drinking water and are difficult to administer quantita­
tively. 
This dissertation represents an effort to characterize the immunity 
induced by a fowl cholera vaccine. It is hoped that these studies 
advance our understanding of the role of humoral and cell-mediated 
immunity in resistance to P. multocida infection. 
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LITERATURE REVIEW 
Characteristics of P. multocida 
Fowl cholera is produced by Pasteurella multocida, a small Gram-
negative rod, of which biochemical and physiological characteristics have 
been described previously (3). A thick capsule composed of hyaluronic 
acid is sometimes present on recently isolated cultures. The Pasteurellae 
are aerobic, but are capable of surviving as facultative anaerobes. 
P^. multocida possesses a free endotoxin, a substance that is 
loosely attached to the bacterium. It can be readily washed off in a 
cold-formalinized saline solution (12,13,14,15,16). The endotoxin is 
immunogenic and produces symptoms of toxicity when given parenterally 
(12,13,15,16). The endotoxin can be concentrated by dialysis and ultra-
centrifugation (12,13,14,15,16). It has been analyzed chemically and has 
been found to contain various carbohydrates, lipids and proteins (14). 
Treatment with phenol destroys immunogenicity. Some portion of the 
immunogenicity is apparently associated with the protein (14). 
The bacterium expresses different antigens when the culture 
conditions are varied. P^. multocida grown in vivo can produce cross-
protection against other strains of P^. multocida whereas agar grown cells 
produce only homologous protection (17,18). P^. multocida grown in vivo 
are susceptible to freeze-thaw lysis, whereas agar grown cells are not 
(19). P^. multocida isolated directly from tissues are immunogenically 
and possibly antigenically different than those grown on agar. These 
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differences may be a source of variability in in vitro studies dealing 
with opsonization and phagocytosis. 
multocida are often difficult to phagocytize. The presence of 
the capsule might act to inhibit phagocytosis (20). The Pasteurellae 
are not considered to be intracellular pathogens. 
Serotypes of P. multocida 
Several methods of serotyping have been developed (21,22,23). 
The two most commonly used are (A) the system of Carter, and (B) the 
system of Heddleston and Rebers. There are four type strains in the 
passive hemagglutination system of Carter. The method of Heddleston 
and Rebers is based on the Ouchterlony gel-diffusion test. Sixteen 
serotypes have been identified by this method. 
Different diseases are produced by different serotypes of P^. 
multocida. Fowl are most commonly infected with P-1059 (type 3 
Heddleston system), or X-73 (type 1, Heddleston system). Both are 
highly pathogenic and produce fowl cholera. The strain X-73 is 
notoriously virulent. It has a LD-100 of one organism for mice (24). 
Infections in humans most commonly result from a cat bite or scratch. 
Respiratory infections have been reported to occur in humans (25). 
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Host-range of P. muUocida 
2» multocida produces disease in a wide range of species. 
Birds fowl cholera 
Bovine shipping fever, mastitis 
Sheep mastitis 
Rabbit snuffles 
Pig pneumonia 
Human cat scratch infection, respiratory 
infections 
£. multocida is often present in apparently healthy farm animals 
( 2 6 ) .  
Immunity induced by fowl cholera vaccination 
The resistance to infection induced by P^. multocida vaccination is 
not entirely understood. Some investigators have been unable to show a 
correlation between serum antibody titers of vaccinated birds and 
resistance to infection (7,27,28), whereas others have indicated that a 
correlation may exist (5,9). Passive protection studies have demon­
strated that immunoglobulin G isolated from the serum of vaccinated 
chickens can induce protection in nonvaccinated chickens (29). 
Recent studies have also indicated that cell-mediated immunity 
may function in resistance (8,10). Maheswaran reported that peripheral 
blood leukocytes from immunized turkeys underwent transformation in the 
presence of various IP. multocida antigens (8). Baba reported that 
surgical or hormonal bursectomy had no effect on mortality in 
vaccinated chickens (30). Significant leukocyte migration inhibition 
was reported in one publication, but not in a second (10,30). 
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It is not known whether humoral or cell-mediated responses 
provide protection in vaccinated birds. In addition, the interaction 
of humoral and cellular response has not been studied. 
Techniques used to analyze the immune response of P. multocida vaccinated 
poultry: selective suppression of antibody responses 
The avian immune system is different from that of mammals. A 
unique structure, the Bursa of Fabricius, acts as a primary lymphoid 
organ. If the organ is removed immediately after hatching, the bird 
will develop a severe antibody deficiency. Bursectomized birds are 
unable to produce a significant antibody response (31,32). In addition, 
levels of circulating immunoglobulins are often reduced. 
The bursectomy procedure produces a suppression of antibody response 
without suppressing cell-mediated immunity. Therefore, it is possible 
to study resistance in vaccinated antibody-deficient birds. Thymus 
dependent functions remain intact and their role in protection can be 
evaluated (32). 
An immunosuppressive tumoricidal drug, cyclophosphamide, can be 
used in a manner analogous to surgical bursectomy. Treatment of newly 
hatched chickens with cyclophosphamide causes a prolonged suppression 
of antibody production and a temporary suppression of cell-mediated 
immunity (33,34,35,36). Antibody responses are abrogated for at least 
ten weeks, whereas cell-mediated responses are reduced for less than 
three weeks. Antibody response and cell-mediated response can be studied 
as separate components when the birds are vaccinated and their 
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resistance is challenged during the fourth through the tenth week after 
treatment. 
Techniques used to analyze the immune response of P.. multocida vaccinated 
poultry; selective suppression of cell-mediated responses 
Niridazole, an antischistosomal drug has been shown to act as a 
suppressant of cell-mediated inmunity in various species, including 
chickens (37,38,39,40,41,42). Niridazole is metabolized, and a product 
of its degradation is bound to serum proteins (43). The serum bound 
metabolite produces T cell suppression. A number of eel 1-mediated 
responses are suppressed including graft-versus-host reactions, delayed 
type hypersensitivity, granuloma formation, lymphocyte transformation, 
and production of migration inhibition factor. Suppression can be 
maintained for up to three weeks after completion of treatment (37). 
It should, therefore, be possible to study resistance in T cell immuno-
deficient chickens by administering niridazole prior to vaccination. 
In vivo tests for delayed hypersensitivity 
Skin testing is a classical means for measuring delayed hyper­
sensitivity (44,45). If a small amount of antigen is placed intradermally 
into a previously sensitized animal, a localized erythema and induration 
may develop. The reaction usually persists for several weeks, and upon 
histological examination an extensive mononuclear infiltrate is seen. 
The presence of such a reaction is used as an indication that delayed 
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type hypersensitivity has developed. 
Granuloma formation is a phenomenon that is closely related to 
the development of skin test reactions. When Mycobacterium tuberculosis, 
Corynebacterium parvum, or certain other antigens are incorporated into 
an adjuvant and injected parenterally, granulomatous lesions develop 
(44). The lesion has the appearance of a hard nodule and can persist 
for several months. Histologically, an extensive mononuclear cell 
infiltrate is seen. Granuloma formation is often indicative of 
delayed hypersensitivity. Antigens can be tested by this method to 
determine if delayed hypersensitivity is produced. 
In vitro tests for delayed-type hypersensitivity 
The leukocyte migration inhibition test is an in vitro correlate 
of delayed hypersensitivity (46). Lymphocytes isolated from the 
peripheral blood of animals may produce leukocyte migration inhibition 
factor (LMIF) after re-exposure to antigen. The LMIF acts to inhibit 
the random migration of polymorphonuclear neutrophils. A number of 
different migration inhibition assays have been described for use with 
avian leukocytes (47,48,49,50,51). The migration inhibition test often 
correlates with skin test reactions. 
The lymphocyte transformation assay is used as an in vitro correlate 
of delayed hypersensitivity (52,53,54,55). Lymphocytes from antigen 
sensitized animals may undergo blast transformation upon re-exposure 
to the antigen. Blast transformation is measured semi quantitatively. 
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and is used as an index of cell-mediated immunity. 
Cell-mediated immune responses 
Cell-mediated immunity is discussed extensively in this dissertation. 
Therefore it is appropriate to elaborate on this topic. 
There are a number "of bacterial pathogens that induce cell-mediated 
immunity. These include Mycobacterium tuberculosis. Brucella abortus, 
and Listeria monocytogenes. The viruses, various fungi, and some 
protozoa also induce cell-mediated immunity (44). Certain hapten-
carrier conjugates such as dinitrophenyl-bovine gamma globulin (DNP-BGG) 
also have this capacity (56,57). 
Macrophages process and present antigen to lymphocytes (58). A small 
number of T lymphocytes, probably less than two percent, are capable of 
undergoing blast transformation in response to antigenic stimulation and 
will form clones derived from individual lymphocytes (59). These 
sensitized T lymphocytes may secrete various lymphokines, and recruit 
and activate new macrophages. Sensitized T lymphocytes also secrete 
lymphotoxins and will kill some tumors in vitro (60). 
Cell-mediated immune responses generally fall into two categories; 
(A) those that involve direct participation of intact lymphocytes in 
the effector mechanism of the reaction (cytotoxic reactions), and (B) 
those that involve participation by lymphokines (delayed hypersensitivity 
and associated phenomena) (45). 
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PART I: PASTEURELLA MULTOCIDA: IMMUNOLOGIC 
STATUS OF CHICKENS AND TURKEYS GIVEN 
INACTIVATED VACCINE 
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SUMMARY 
Turkeys were shown to be more susceptible than chickens to 
Pasteurella multocida challenge infection. A formal in-inactivated 
Pj. multocida bacterin produced a significant level of protective 
immunity in chickens and turkeys. 
In turkeys, vaccination induced an antibody response that 
rapidly increased until the 10th day after vaccination. The 
antibody titers then remained relatively unchanged. A second 
vaccination induced a four-fold increase in antibody titers. 
The results indicate that it is feasible to use the formalin 
inactivated bacterin in studies of the immunity produced by 
vaccination. 
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INTRODUCTION 
Fowl cholera is recognized as a potentially severe poultry disease. 
Antibiotics are often added to the feed ration to act prophylactically 
against various diseases including fowl cholera. Some poultry management 
programs use a combination of antibiotics and vaccination to prevent 
cholera. 
Certain species of birds are more susceptible to fowl cholera 
infection than others. Turkeys are more commonly infected than chickens. 
Vaccination provides a degree of protection in both chickens and 
turkeys (1). 
There are two types of commercial vaccines: (A) live attenuated 
£.• multocida or (B) formalin inactivated P^. multocida suspended in 
Freund's incomplete adjuvant. 
Poultry growers are sometimes reticent to use live fowl cholera 
vaccines in areas where the disease is not endemic (2). Occasional 
outbreaks of the disease have been attributed to the use of attenuated 
vaccine strains. 
To develop more effective vaccines, the resistance produced by 
iP. multocida vaccination needs to be more thoroughly characterized. 
This paper reports the results of a preliminary study that was made to 
determine the feasibility of using the formalin-inactivated bacterin 
in a study of the immunity produced by vaccination. Several factors 
were analyzed including (A) the susceptibility of nonvaccinated chickens 
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and turkeys to challenge exposure, (B) the protective effect of 
vaccination, (C) the development of antibody response following 
vaccination, and (D) the effect of revaccination on antibody response. 
15 
MATERIALS AND METHODS 
Preparation of vaccine 
multocida, strain 1059 was grown on tryptose agar in Roux 
bottles for 18 hours at 37 C. The cells were washed off the agar 
surfaces with sterile saline and put into a sterile flask. Bacterial 
counts were determined by preparing serial dilutions in saline, 
followed by plating on agar. The concentration was adjusted to 10^ 
cells/ml of saline. Formalin was then added to the flask to a final 
concentration of 0.3% of the total volume, and the flask was kept at 
room temperature for 18 hours to kill the bacteria. A sample of 
the formalinized bacterial suspension was tested by plating on 
tryptose agar to determine sterility. No colony growth was detected 
after the formalin treatment. The bacterial suspension was combined 
in a ratio of 1:1 v/v with Freund's complete adjuvant (Difco) and 
was used as vaccine. 
Tube agglutination test 
Antigen was prepared by growing and harvesting the bacteria in the 
same manner as described for the preparation of the vaccine. Strain 1059 
has a capsule which was removed by acid treatment. After addition 
of formalin, bacteria were centrifuged at 21,000 x G for 15 minutes in a 
Sorval RC-2B centrifuge. The pellet was suspended in 150 ml of 1 N 
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HCl acid-saline solution and incubated for 18 hours at 37 C. The cells 
were then washed and centrifuged twice with phosphate buffered saline 
plus 0.3% formalin, pH 5.8. The cell concentration was adjusted to 
equal an optical density of 0.34 as determined in a Spectronic 20 
spectrophotometer at a wavelength of 600 nm. Phosphate buffered 
saline plus 0.3% formalin was used as the diluent. For the agglutina­
tion test, a twofold dilution of the antisera being tested was used 
in each tube. Antigen (1 ml) and diluted antiserum (1 ml) were 
combined in each tube and were incubated at 37 C for 18 hours. The 
agglutination end point was then determined and recorded as the 
agglutination titer (reciprocal of the end point dilution). 
Part I - Susceptibility studies: protection studies 
One group of eight three-week-old chickens received a single 
subcutaneous injection of 1 ml of the iP. multocida vaccine. A second 
group of six chickens was used as the control and was not vaccinated. 
The birds were challenge exposed at six weeks of age with 10,000 
viable P^. multocida by intramuscular injection into the thigh. 
One group of eleven three-week-old turkeys also received a single 
subcutaneous injection of 1 ml of the P^. multocida vaccine. A second 
group of eight turkeys was not vaccinated and was used as control. 
The birds were then challenge exposed in the same manner as the 
chickens. 
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Part II - Development of antibody titers following vaccination and 
revaccination 
Three twelve-week-old turkeys received a subcutaneous injection 
of 1 ml of the multocida vaccine. Agglutination antibody titers 
were measured at three-day intervals. A second vaccination was given 
26 days after the initial vaccination. Three ml of blood was drawn 
from the wing vein of each bird on every third day. The antisera 
were tested using the agglutination procedure described above. 
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RESULTS 
Differences in susceptibility to challenge exposure between nonvaccinated 
chickens and turkeys 
Nonvaccinated turkeys were more susceptible to challenge infection 
than nonvaccinated chickens. All of the turkeys were dead within 48 
hours after challenge exposure. Chickens did not start dying until four 
days after challenge exposure. Mortality reached 66 percent (Fig. 1). 
Other experiments by this author have demonstrated that in groups of 
nonvaccinated chickens mortality may reach 100% when a larger challenge 
exposure is given (data not shown). However, the development of 
clinical signs and mortality is always delayed in chickens in comparison 
to turkeys. 
Protective effect of vaccination 
Vaccination of three-week-old birds reduced mortality significantly 
when challenge exposure was given at six weeks of age. In turkeys, 
mortality was reduced from 66% to 12% (Fig. 1). Vaccinated birds that de­
veloped fowl cholera succombed at least three days later than nonvaccinated 
birds (Fig. 1). Other experiments completed by this author have 
demonstrated that mortality may reach 25% in vaccinated chickens when a 
larger challenge dose is given (data not shown). 
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Development of antibody titers following vaccination 
The geometric mean agglutination titer {G.M.T., geometric mean of 
the reciprocal of the end point dilution) rapidly increased following 
vaccination. By day 10 following vaccination a G.M.T. of 56 was 
recorded. The G.M.T. then remained relatively unchanged until the 
turkeys were revaccinated (Fig. 2). 
Effect of revaccination on agglutination titers 
Revaccination on day 26 produced a transitory drop in G.M.T. 
followed by a dramatic rise, A 4.5-fold increase in G.M.T. was seen. 
The G.M.T. increased to 224 following the revaccination (Fig. 2). 
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DISCUSSION 
A number of factors are important when evaluating P^. multocida 
vaccines. These factors include the level and duration of protection 
and need for revaccination. In addition, a successful £. multocida 
vaccine must be able to induce cross-protection against different 
£. multocida serotypes. Cross-protection is at least partially 
dependent on the method used to grow P^. multocida (3). 
It is evident that the development of P^. multocida vaccines will 
be facilitated by a deeper understanding of the immunity induced 
by vaccination. The immunologic mechanisms mediating resistance are 
not well-understood. Certain aspects need to be more clearly elucidated, 
particularly the relationship of antibody titer to protection (4,5) 
and the role of cell-mediated immunity in protection (6,7,8,9). 
These results confirm that a formalin inactivated bacterin 
provides a substantial level of protection in chickens and turkeys. 
Revaccination increased agglutination titers significantly. The 
results demonstrate that there is a distinct difference between chickens 
and turkeys in their susceptibility to challenge infection and in 
their response to vaccination (Fig. 1). There is no known reason for 
this phenomenon. 
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The results from this study suggest that the immunity produced by 
inactivated adjuvanted bacterins is of sufficient duration and 
magnitude so that this method of vaccination could be used in further 
studies where a more detailed analysis of the immune response will be 
made. 
Figure 1. Mortality of vaccinated and nonvaccinated chickens and 
turkeys after challenge exposure to strain P-1059 
• nonvaccinated turkeys (n=8). 
• vaccinated turkeys (n=ll). 
A nonvaccinated chickens (n=6). 
• vaccinated chickens (n=8). 
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Figure 2. Development of agglutination antibody titers following 
vaccination of turkeys with P-1059 bacterin (n=3). 
Geometric mean titer is expressed as the geometric mean 
of the reciprocal of the end point dilution. 
A indicates revaccination on day 26. 
25 
250 
200 
150 
50 
20 30 35 10 15 40 5 
D A Y S  P O S T - V A C C I N A T I O N  
26 
REFERENCES CITED 
1. Heddleston, K. L., and K. R. Rhoades. 1978. Avian Pasteurellosis. 
Pages 181-199 in M. S. Hofstad, ed. Diseases of Poultry 
7th edition. The Iowa State University Press, Ames, Iowa. 
2. Matsumoto, M., and D. H. Heifer. 1977. A bacterin against fowl 
cholera in turkeys: Protective quality of various preparations 
originated from broth cultures. Avian Dis. 21:382-392. 
3. Rimler, R. B., P. A. Rebers, and K. R. Rhoades. 1979. Modulation 
of cross-protection factor(s) of avian Pasteurella multocida. 
Avian Dis. 24:989-998. 
4. Coates, S. R., M. M. Jensen, and E. D. Brown. 1977. The response 
of turkeys to varying doses of live oral Pasteurella multocida 
vaccine. Poult. Sci. 56:273-276. 
5. Dua, S. K., and S. K. Maheswaran. 1978. Studies on Pasteurella 
multocida. VI. Nature of systemic immunity and analysis of 
the correlation between levels of immunity induced by various 
fowl cholera vaccines and protection against challenge. Avian 
Dis. 22:748-764. 
6. Yamaguchi, Y., and T. Baba. 1974. Demonstration in tissue 
culture of cellular immunity to fowl cholera. Pages 14-18 
in T. Hasegawa ed. Proceedings of the First Intersectional 
Congress of the lAMS. Vol. 4. Science Council of Japan, Tokyo. 
7. Baba, T., T. Ando, and M. Nukena. 1978. Effect of bursectomy 
and thymectomy on Pasteurella multocida infection in chickens. 
J. Med. Microbiol. 11:281-288. 
8. Maheswaran, S. K., E. S. Thies, and S. K. Dua. 1976. Studies on 
Pasteurella multocida. III. In vitro assay for cell-mediated 
immunity. Avian Dis. 20:332-341. 
9. Maheswaran, S. K., S. K. Dua, and E. S. Thies. 1980. Studies on 
Pasteurella multocida. IX. Levamisole-induced augmentation 
of immune responses to a live fowl cholera vaccine. Avian. Dis. 
24:71-81. 
27 
PART II: PASTEURELLA MULTOCIDA: ANTIBODY MEDIATED 
RESISTANCE TO VIRULENT CHALLENGE EXPOSURE 
IN VACCINATED TURKEYS 
This paper was published in the American Journal of 
Veterinary Research 41:1285-1287 (1980) 
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SUMMARY 
Aspects of antibody mediated resistance to Pasteurella muTtocida 
infection in vaccinated turkeys were investigated. multocida 
immune serum obtained from vaccinated turkeys was shown to confer 
temporary protection to nonvaccinated turkey poults. Recipients given 
immune serum were free of clinical signs of disease for at least 8 days 
after intramuscular (IM) challenge exposure with virulent multocida 
1059. All turkeys given normal serum died within 36 hours of challenge 
exposure. 
Vaccinated bursectomized turkeys were more susceptible to IM 
challenge exposure than were vaccinated nonbursectomized turkeys. In 
two of three trials, mortality also occurred earlier in the bursectomized 
turkeys. The presence of specific antibody may be an important determ­
inant in resistance to P. multocida infection. 
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INTRODUCTION 
Many domestic and wild animals are susceptible to infection with 
Pasteurella multocida. In poultry, P. multocida produces fowl cholera 
and often fatal septicemia. The mechanisms of resistance to fowl 
cholera stimulated by vaccination remain controversial. Some investi­
gators have not been able to show a correlation between serum antibody 
titers in vaccinated turkeys and resistance (1,2), whereas others have 
indicated that a correlation exists (3). There is also some evidence 
that indicates that cell-mediated immunity may function in resistance 
to 2" multocida in vaccinated turkeys (4). To develop more effective 
vaccines, the mechanisms of resistance to P^. multocida need to be 
better understood. 
The purpose of the present report is to indicate the importance of 
antibody response in resistance to IM P^. multocida challenge exposure. 
Two methods were used to evaluate in vivo antibody activity: (A) the 
induction of passive protection by transfer of immune sera from 
vaccinated turkeys, (B) the determination of susceptibility of 
vaccinated bursectomized turkeys to virulent JP. multocida 1059 
challenge exposure. 
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MATERIALS AND METHODS 
Preparation of vaccine 
Pasteurella multocida strain 1059 was grown on tryptose agar 
in Roux bottles for 18 hours at 37 C. The bacteria were washed from 
the agar surfaces with sterile saline solution and were pooled in a 
sterile flask. Bacterial counts were obtained by making serial dilutions 
in saline solution followed by plating on agar. The concentration of 
£. multocida was adjusted to 10^ cells/ml of saline solution. Formalin 
was then added to the flask to a final concentration of 0.3% of the 
total volume and the flask was kept at room temperature for 18 hours 
to kill the bacteria. A sample of the formalinized bacterial suspension 
was tested by plating on tryptose agar to determine sterility. The saline 
suspension of £. multocida was combined in a ratio of 1/1 v/v with 
Freund's complete adjuvant and was used as vaccine. 
Production of antisera 
Antisera against P^. multocida strain 1059 were produced in three 
Broad Breasted White turkeys that were given two subcutaneous injections 
each of 0.1 ml of the vaccine and two injections each of 1 ml given 
intraperitoneally. Injections were administered at three-week intervals. 
Blood samples were collected 2 weeks after the final injection, and the 
serum was separated and heated at 56 C for 30 minutes and then pooled. 
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Normal serum samples were obtained from several nonvaccinated 
turkeys, heat treated, and pooled. 
Approximately 100 ml of serum was obtained from each of the groups. 
Passive protection - (Experiment I) 
Three-week old nonvaccinated turkey poults were used as recipients 
of antiserum against P^. multocida or normal serum. Eight poults were 
each injected IV with 8 to 9 ml of antiserum. Seven poults were each 
injected IV with 8 to 9 ml of normal serum. Signs of distress were not 
observed after the large transfusions. Twenty-four hours after passive 
serum transfers, each poult was inoculated IM with 2000 viable P^. 
multocida organisms in the thigh. 
Studies with bursectomized turkeys - (Experiment II) 
Removal of the Bursa of Fabricius in the chicken diminishes or 
eliminates antibody response but leaves cell-mediated responses essentially 
intact (5). Turkeys were used instead of chickens in the present study 
because of their greater susceptibility to P^. multocida infection. 
Fertile turkey eggs were purchased from a local hatchery and were 
incubated. Within 24 hours of hatching, a group of birds was bur­
sectomized and another group was left intact and used as controls. The 
area immediately dorsal to the cloaca was cleared of feathery down and 
was wiped with an alcohol swab. A small perforation was made and widened 
with the tips of sharp forceps. Mild pressure was applied to the abdomen 
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to move the bursa into proximity to the incision. Sterile forceps 
were inserted through the incision and the suspensory tissue located 
just dorsal to the bursa was teased away. The forceps were then moved 
in a cranial direction over the surface of the bursa. The apex of the 
bursa was grasped and pulled through the incision. The bursa was then 
cut at the stalk. Nitrofurazone antibacterial powder^ was applied to the 
wound sitsv Healing normally occurred within 2 or 3 days. All poults 
used in the experiment were kept together in a heated disinfected room 
and were given autoclaved feed. 
Bursectomized and nonbursectomized poults were vaccinated at 3 weeks 
of age with a single subcutaneous injection of 1 ml of vaccine. The 
poults were challenge exposed at 6 weeks of age, with 2,000 viable JP. 
multocida organisms by IM inoculation into the thigh. The IM challenge 
route was chosen because it is quantitative and reproducible. 
Experiment II wa,> conducted as three separate trials (Table 1). 
Tube agglutination test 
£o multocida strain 1059 has a capsule that must be removed by 
acidic or enzymatic treatment for agglutination to occur. 
Agglutination antigen was prepared by growing and harvesting the bacteria 
in the same manner as described for the preparation of the vaccine. 
2 Formalinized bacteria were centrifuged at 21,000 x g for 15 minutes. 
^Furacin soluble powder, Easton Veterinary Laboratories, Morton 
Norwich Products Inc., Norwich, NY. 
^Sorvall RC 2-B, Ivan Sorvall Inc., Newtown, CT. 
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The pellet was then suspended in 150 ml of 1 N HCl saline solution and 
was incubated at 37 C for 18 hours. Cells were centrifuged again and 
were washed twice with formalinized PBSS (pH 5.8). The cell concentra­
tion was then adjusted to equal an optical density of 0.648 on a 
spectrophotometer^ at a wave length of 600 nm. Formalinized PBSS 
(pH 5.8) was used as the diluent. A two-fold dilution of the antisera 
being tested was used in each tube. Antigen (1 ml) and antiserum 
(1 ml) were combined in each tube and were incubated at 37 C for 18 
hours. 
^Bausch and Lomb, Rochester, NY. 
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RESULTS 
Passive protection - (Experiment I) 
Passive protection was indicated when poults survived challenge 
exposure with £. multocida 1059. The poults given normal serum showed 
clinical signs of disease 24 hours after challenge exposure, and 100% 
died within 36 hours. Poults given antiserum from vaccinated turkeys 
developed a temporary resistance as indicated by delayed mortality 
from day 8 to 13 after challenge exposure (Fig. 1). Of eight poults, 
two given antiserum survived the challenge exposure. 
Effect of bursectomy on resistance in vaccinated turkeys - (Experiment II) 
Poults that were bursectomized, vaccinated, and challenge exposed, 
were less resistant than were nonbursectomized vaccinated controls 
(Table 1). Mortality was significantly higher (P<0.05, test) in the 
bursectomized group than in the controls. Deaths began to occur earlier 
in two of three trials, in the bursectomized group (Fig. 2). Bursectomized 
poults which had been vaccinated also produced some detectable antibody 
as demonstrated by the agglutination of IP. multocida. However, antibody 
levels were considerably depressed in the sera of bursectomized poults. 
Generally, the antibody titers correlated with observed resistance 
(Table 2). 
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DISCUSSION 
The present results confirm and extend the evidence for antibody 
mediated protection against _P. multocida infection in vaccinated turkeys. 
The data obtained confirm the results of Rebers and Heddleston who 
demonstrated that passively transferred antiserum can protect against 
challenge exposure (6). The data also indicate that vaccinated bur-
sectomized turkeys were more susceptible to IM challenge exposure with 
P^. multocida than were vaccinated turkeys that were not bursectomized. 
Turkeys given antiserum survived IP. multocida challenge exposure for 
8 days whereas the control birds died within 36 hours after challenge 
exposure. These observations indicate that antibody against P^. multocida 
has the capacity to suppress clinical signs of disease and mortality. 
Recent studies by Hofing et al. are interesting in view of these results 
(7). They found that rabbit antiserum against P^. multocida was not 
bactericidal and did not enhance phagocytosis when compared with normal 
serum in in vitro tests. This apparent discrepancy between their in 
vitro results and the present in vivo results may be due to a modifica­
tion of 2' multocida organisms under different growth conditions. Changes 
in the organisms can be inferred from certain observations. When P^. 
multocida is isolated from the blood or tissues of turkeys and is used 
as a formalini zed bacterin, it is capable of inducing cross-protection 
in turkeys against challenge exposure by heterologous strains. 
However, P. multocida from agar-grown cultures protects only 
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against challenge exposure by the homologous strain (8). In addition, 
multocida isolated directly from infected tissues are lysed by 
freeze-thaw cycles whereas agar-grown cells are not (9). Conceivably, 
the aforementioned cited differences between in vivo and in vitro grown 
multocida organisms may be extended to differences in susceptibility 
to bactericidal and opsonizing activities of antibodies. 
The role of immunoglobulin (Ig)G in protection against 2- multocida 
challenge exposure has been demonstrated in passive protection studies 
by Rebers and Heddleston (6). They have established that IgG antibody 
from turkeys immunized with P^. multocida infected tissues, could 
passively cross-protect chickens against agar-grown multocida 
almost as well as whole antiserum. 
The vaccinated bursectomized turkey poults used in this study 
produced less P^. multocida antibody than did vaccinated nonbursectomized 
poults. The bursectomized group also had less resistance to challenge 
exposure. The bursectotny experiments indicate that there is a re­
quirement for humoral response in the development of resistance to £. 
multocida. 
The bursectorny results obtained with turkeys do not agree with 
results reported by Baba et al^. (10). These authors did not observe 
antibody dependent protection in vaccinated chickens that had been 
bursectomized. 
The initial site of infection by P^. multocida under field conditions 
is usually the respiratory system. However, conclusive evidence has not 
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been obtained which indicates that local respiratory immunity is 
induced by P^. multocida infection or vaccination. There is no known 
selective advantage in giving IM challenge exposure vs. aerosol challenge 
exposure in demonstrating the relevance of circulating antibody to 
protection. The IM route was chosen for challenge exposure to 
deliver uniform and quantitative doses. It is possible that antibodies 
which suppress systemic challenge exposure infections also may function 
in local respiratory immunity. Further studies are necessary to 
clarify the role of antibodies in local respiratory immunity. 
The present results suggest that presence of antibody may be an 
important determinant in resistance of turkeys against IM challenge 
exposure infection with £. multocida. 
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ADDENDUM 
At the time this manuscript was being prepared it was found, in 
preliminary results, that treatment of newly hatched chickens with 
cyclophosphamide, a potent suppressor of antibody production, diminished 
the effectiveness of vaccination against challenge exposure. This 
observation further suggests that antibodies have a role in development 
of resistance. 
39 
Table 1. (Experiment II) Effect of bursectomy on resistance to 2-
multocida challenge exposure in turkeys. Ratios shown 
represent (Number dead/number challenge exposed). Bx = 
bursectomized. Vacc = vaccinated. 
Trial Bx + Vacc Vacc only No Bx, No Vacc 
Trial 1 7/8 3/7 3/3 
Trial 2 9/12 4/11 3/3 
Trial 3 12/13 8/13 3/3 
Cumulative % 85% 47% 100% 
Table 2. (Experiment II) Effect of bursectomy on antibody titers 
(Reciprocal of dilution) against P. multocida in vaccinated 
turkeys and relationship to challenge exposure mortality. 
Results are from turkeys randomly selected in trial two at 
one day before challenge. Bx = bursectomized. Vacc = 
vaccinated. 
' 
Group Bird Titer Status 
Bx + Vacc 374 160 Dead 
381 10 Dead 
382 80 Dead 
389 80 Dead 
391 5 Dead 
392 10 Dead 
393 40 A1 i ve 
Vacc only 485 320 A1 i ve 
495 320 A1 i ve 
497 1280 A1 i ve 
501 80 A1 i ve 
504 40 Dead 
Figure 1. (Experiment I) Mortality rate of IP.  multocida 
challenge exposed turkeys given 8 to 9 ml of 
turkey serum 24 hours before challenge exposure 
Normal serum (n=7). 
Immune serum (n=8). 
Figure 2. (Experiment II) Mortality rate of JP. multocida 
challenge exposed turkeys 
0 Bursectomized and vaccinated (n=12). 
# Vaccinated only (n=ll). 
This pattern seen in two of three trials. 
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PART III: CYCLOPHOSPHAMIDE-INDUCED IMMUNOSUPPRESSION 
DEMONSTRATED IN PASTEURELLA MULTOCIDA 
VACCINATED CHICKENS 
This paper has been accepted for 
publication in Avian Diseases 
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SUMMARY 
Vaccinated cyclophosphamide-treated chickens were more susceptible 
to challenge infection than vaccinated untreated chickens. Antibody 
titers were greatly reduced in cyclophosphamide-treated chickens. The 
results suggest that the presence of specific antibody is an important 
determinant in the ability of chickens to resist £. multocida infection. 
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INTRODUCTION 
In poultry, Pasteurella tiiultocida produces fowl cholera, which 
often results in high mortality. The type of immunity stimulated by 
vaccination is still controversial. Some investigations have indicated 
that cell-mediated immunity plays a role in resistance to challenge 
infection (1,2). Other work suggests that antibody-mediated immunity 
is a determinant of challenge resistance (3,4,5,6). 
In this study, a tumoricidal agent, cyclophosphamide, was used to 
diminish or eliminate antibody response in chickens, and to evaluate the 
relative importance of antibody to resistance of vaccinated chickens to 
P^. multocida challenge. 
Treatment of newly hatched chickens with cyclophosphamide causes 
suppression of antibody production for at least 10 weeks. Cell-mediated 
immunity is suppressed for less than one month (7,8,9,10). Histological 
studies provide evidence for this differential suppression (8,9). 
Cyclophosphamide treatment causes severe and often permanent depletion 
of bursal cells and chronic degenerative changes in the bursal structure. 
Spleens show an absence of germinal centers and plasma cells. Initially, 
the lymphoid population of the thymus decreases, but it is rapidly 
repopulated within two or three weeks after treatment is completed. 
Cellular immunological functions of birds treated in the newly hatched 
period appear to recover by three to four weeks of age (7,8,9,10). 
Allograft rejection and graft-versus-host reactivity are restored by this 
age. 
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As a result of this differential suppression, one may evaluate 
the protective components of the immune response in vivo against 
challenge infection. 
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MATERIALS AND METHODS 
Fertile chicken eggs were incubated and hatched. Within 24 hours 
of hatching one group of chickens received intramuscular injections of 
4 mg cyclophosphamide.^ The chickens were given daily injections for 
four days. A second group, not treated with cyclophosphamide, served 
as controls. The birds were kept in heated batteries and fed ad 
libitum. 
2. multocida strain 1059 was grown on tryptose agar in Roux 
bottles for 18 hours at 37 C. Bacteria were harvested in sterile saline 
and placed into a sterile flask. Bacterial counts were obtained by 
serial dilution in saline and plating on tryptose agar. The concentration 
of P^. multocida was adjusted to 10^ cells/ml saline. Formalin was then 
added to the flask to a final concentration of 0.3% of the total volume 
and held at room temperature for 18 hours to kill the bacteria. No 
viability was detected after the formalin treatment. The bacterial 
suspension was combined in a ratio of 1:1 v/v with Freund's complete 
adjuvant (Difco) and used as vaccine. 
Both groups of chickens were vaccinated 26 days after the last 
administration of cyclophosphamide. Each bird was given a single 
subcutaneous injection of 1 ml of the vaccine. 
Antibody titers were determined by a bacterial agglutination test. 
Strain 1059 has a capsule, which was removed by acid treatment. An 
^Cytoxan, Mead Johnson Laboratories, Evansville, IN. 
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agglutination antigen was prepared by growing and harvesting the 
bacteria as described above. Formalinized bacteria were centrifuged at 
21,000 X G in a Sorvall RC2-B centrifuge for 15 minutes. The pellet 
was then suspended in 150 ml of 1 N HCl saline solution and incubated 
at 37 C for 18 hours. The cells were washed and centrifuged twice 
with formalinized phosphate-buffered saline, pH 5.8. The cell con­
centration was adjusted to an optical density of 0.34 as determined in 
a Spectronic 20 spectrophotometer^ at a wave length of 600 nm. 
Formalinized phosphate-buffered saline, pH 5.8, was used as the diluent. 
Antiserum was obtained from each chicken one day before challenge 
exposure. In the agglutination test, twofold dilutions of antiserum in 
1 ml of diluent were mixed with 1 ml of the antigen and incubated at 37 C 
for 18 hours. The agglutination end point was then determined and 
recorded as the titer (reciprocal of dilution). 
The chickens were challenged 21 days after vaccination with either 
2 X 10® (trial 1) or 2 x 10® (trial 2) P.. multocida given by intra­
muscular inoculation into the thigh. The chickens were observed for 21 
days after the challenge and mortality was recorded. 
^Bausch and Lomb, Rochester, NY. 
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RESULTS 
Vaccinated cyclophosphamide-treated chickens were more susceptible 
to challenge infection than were the vaccinated untreated chickens 
(Table 1). All of the cyclophosphamide-treated chickens died from the 
challenge infection. Mortality was significantly higher (p<0.01, 
test) in the cyclophosphamide-treated group than in the control group. 
Three of 17 treated chickens produced agglutinating antibody against 
IP. multocida. All untreated birds produced agglutinating antibody 
(Table 1). 
Five of 19 vaccinated chickens died, but they survived longer than 
most of the vaccinated cyclophosphamide-treated chickens (Fig. 1). 
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DISCUSSION AND CONCLUSIONS 
The results suggest that there is a correlation between the 
presence of antibody and of the ability of vaccinated chickens to resist 
multocida. This agrees with previous experiments that demonstrated 
that vaccinated surgically bursectomized turkeys were more susceptible 
to challenge with K multocida (11). Cell-mediated immunity may not 
be the primary means of protection with this method of vaccination. 
Clearly, it would be an asset to confirm that the cyclophosphamide 
treatment did not suppress cell-mediated responses to £. multocida. 
Unfortunately, this laboratory has not successfully established an 
assay for cell-mediated immunity to £. multocida. Other studies with 
cyclophosphamide suggest that cell-mediated immunological functions are 
restored by the fourth week post-treatment (7,8,9,10). In these 
experiments, approximately seven weeks elapsed between completion of 
cyclophosphamide treatment and time of challenge. 
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Table 1. Suppressive effect of cyclophosphamide. Reduction of 
agglutinating antibody titers of chickens vaccinated with 
P. tnultocida and relationship to mortality after challenge. 
Antiserum was obtained from each chicken one day before 
challenge exposure 
Trial Treatment Antibody titer® Mortality^ 
1 Cyclophosphamide 0-5 9/9 
None 40-320 3/9 
2 Cyclophosphamide 0-10 8/8 
None 40-1280 2/10 
Reciprocal of dilution, range of titer of group. One treated 
bird produced detectable titer in Trial 1. Two treated birds produced 
detectable titers in Trial 2. 
^Number dead/number challenged. 
Figure 1. Mortality of vaccinated chickens to P^. multocida 
challenge infection 
Data are pooled from trials 1 and 2 .  
Cyclophosphamide-treated (n=17). 
4 Untreated (n=19). 
Percent Cumulative Mortality 
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PART IV: IN VIVO TESTS FOR DELAYED TYPE HYPERSENSITIVITY 
W PTRTEURELLA MULTOCIDA IN VACCINATED CHICKENS 
AND TURKEYS 
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SUMMARY 
In vivo tests were developed in order to determine whether delayed 
type hypersensitivity is induced by Pasteurella multocida vaccination. 
Chickens and turkeys were vaccinated with a formalin inactivated 
multocida bacterin. The birds were studied by skin testing, 
evaluation of granuloma formation, and treatment with niridazole, 
an immunosuppressive drug. 
Vaccinated chickens and turkeys did not appear to develop delayed 
type hypersensitivity in these studies. 
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INTRODUCTION 
The immune response to Pasteurelia multocida vaccination is not 
well-understoodo In vaccinated poultry both humoral and cell-mediated 
immunity may be important in resistance to challenge infection (1). 
Certain in vitro tests have indicated that cell-mediated immunity may 
be induced by vaccination (2,3). There have not been any reports of 
in vivo tests that were used to evaluate cell-mediated immunity 
and delayed hypersensitivity to IP. multocida. This report presents the 
results of a preliminary study in which in vivo tests were developed. 
Delayed type hypersensitivity: the phenomenon 
Cell-mediated immune responses fall into two general categories, 
(A) those that involve direct participation of intact lymphocytes in the 
effector mechanism of the reaction (cytotoxic reactions), (B) those that 
involve participation by lymphokines (delayed type hypersensitivity and 
associated phenomena) (4). 
Delayed type hypersensitivity reactions (hereafter called DTH 
reactions) are inflammatory in nature, and are characterized by the 
infiltration of mononuclear cells into areas of antigen deposition (5). 
The macrophages present in DTH infiltrates are activated. 
Various intracellular bacteria, protozoa, fungi, and viruses induce 
macrophage activation. However, not all antigens possess this capacity. 
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Activated macrophages process and present antigen to lymphocytes. 
About two percent of the total lymphocyte population is capable of 
undergoing blast transformation in response to antigenic stimulation and 
will form clones derived from individual lymphocytes (6). A greatly 
expanded population of lymphocytes develops that is capable of responding 
to the antigen. T lymphocyte blasts can produce lymphokines and various 
effector substances when they are exposed to antigen. The production of 
lymphokines by T lymphocytes is considered to be a hallmark of DTH and 
cell-mediated immunity. 
The purpose of this study was to determine whether DTH has a role 
in resistance to £. multocida infection. DTH responses were analyzed by 
skin testing, evaluation of granuloma formation, and drug induced 
immunosuppression. 
In vivo tests for DTH 
Skin test reactions and granuloma formation result from the same 
pathogenetic mechanism (5). In both cases cellular reactions localize 
around foci of antigen. The skin test reaction is more diffuse than are 
granulomatous reactions (5). 
Immunosuppressive drugs can be used to evaluate DTH. Niridazole, 
an antischistosomal drug, has been shown to suppress DTH in man, chickens, 
mice, and rats (7,8,9,10,11). The drug has no apparent suppressive 
effect on humoral immunity (12). Some studies have shown enhancement of 
antibody response (7). Niridazole has low toxicity when used in doses 
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of less than 100 mg/kg body weight (7,13). When niridazole is 
ingested orally, it is metabolized and becomes bound to serum proteins 
(14). The metabolite remains bound for at least three weeks, and 
immunosuppression exists throughout this period. 
Chickens were treated with niridazole to produce a suppression 
of cell-mediated immunity. Later the chickens were challenge exposed 
and the requirement for a protective cellular response was evaluated. 
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MATERIALS AND METHODS 
Preparation of vaccine 
IP. multocida, strain 1059, was grown on tryptose agar in Roux 
bottles for 18 hours at 37 C. Bacterial counts were obtained by 
making serial dilutions in saline followed by plating on agar. The 
Q 
concentration of P^. multocida was adjusted to 10 cells/ml of saline. 
Formalin was then added to the flask to a final concentration of 0.3% 
of the total volume. Eighteen hours later a sample of the formalinized 
bacterial suspension was tested by plating on tryptose agar to determine 
sterility. The bacterial suspension was combined in a ratio of 1:1 
v/v with Freund's complete adjuvant and used as vaccine. 
Skin Tests 
Preparation of skin test reagents 
Two skin test reagents were used: (A) formalin inactivated 
multocida, strain 1059, and (B) formalin inactivated sonicated P^. 
multocida, strain 1059. 
Reagent A consisted of formalin inactivated P^. multocida at a 
concentration of TO® bacteria/ml formalin-saline. Reagent B consisted 
of formalin inactivated sonicated P^. multocida at a concentration of 10^ 
bacteria/ml formalin-saline. The preparation was sonicated in a 
Bronwill Biosonik IV sonicator for eight thirty-second pulses with a 
high intensity probe.^ 
^VWR Scientific, San Francisco, CA. 
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Skin test with reagent A 
Two groups of turkeys were used. One group of four turkeys was 
given two subcutaneous injections each of 0.1 ml of the vaccine and two 
injections each of 1 ml of the vaccine given intraperitoneally. A 
second group of three turkeys was not vaccinated and was used as control. 
Two weeks after the second vaccination the birds in both groups received 
an intradermal injection of 0.1 ml of the reagent A. Skin test reactions 
were measured with a ruler after 48 hours had elapsed. 
Skin test with reagent B 
Two groups of turkeys were used. The turkeys were three weeks old, 
and were housed together. In one group of nine turkeys, each bird 
received 1 ml of the vaccine intraperitoneally. Three weeks later the 
vaccination was repeated. A second group of nine turkeys was not 
vaccinated and was used as a control group. Two weeks after the second 
vaccination the birds in both groups received an intradermal injection 
of 0.1 ml of reagent B. Skin test reactions were measured with a ruler 
after 48 hours had elapsed. 
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Evaluation of Granuloma Formation 
Preparation of materials 
(A) Lyophilized and killed Mycobacterium tuberculosis strain R37a^ 
was combined with a 1:1 v/v mixture of Freund's incomplete 
adjuvantrsaline. The concentration of M. tuberculosis was 
adjusted to 5 mg/ml of emulsion. 
(B) 2" multocida, strain 1059, was harvested and decapsulated 
by a method described previously and then lyophilized (15). 
The lyophilized killed P^. multocida was combined with a 1:1 
v/v mixture of Freund's incomplete adjuvant:saline. The 
concentration of P^. multocida was adjusted to 5 mg/ml of 
emulsion. 
(C) A negative control consisted of a 1:1 v/v mixture of Freund's 
incomplete adjuvant;saline. 
Chickens 
Three groups of nine chickens were used. The chickens were six 
weeks old, and were housed together. In one group, each chicken 
received 1 ml of the M. tuberculosis emulsion subcutaneously. In a second 
group, each chicken received 1 ml of the P^. multocida emulsion. 
The chickens in the third group each received the negative control 
consisting of the adjuvant emulsion alone. The chickens were examined 
for granulomas by palpation. 
^Difco, Detroit, MI. 
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Drug Induced Immunosuppression 
Niridazole 
Niridazole^ was suspended in distilled water. Dosage was 
calculated on the basis of body weight. The mean body weight of the 
chickens was 762 + 97 grams (six birds were weighed). Niridazole was 
suspended in distilled water so that one ml provided a dosage of 
75 mg/kg body weight. The drug was given orally by gavage using 
a 2 1/2 inch hypodermic needle with a ball tip. 
Chickens 
Three groups of chickens were used. The chickens were six weeks 
old and were housed together. One group of six chickens received 
one ml of niridazole suspension daily, for a period of five days. On 
the second day of treatment the chickens were vaccinated subcutaneously 
with 1 ml of the vaccine described above. A group of five chickens 
was used as the vaccine control group. The control group was vaccinated 
on the same day as the group receiving niridazole. The control group 
was not treated with the drug. Another group of four chickens was 
left untreated and unvaccinated. 
Challenge infection 
Blood was drawn from the wing vein of each chicken on the day 
preceding challenge infection. Agglutination titers were determined 
^Ciba-Geigy Corp., Summit, NJ. 
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by a method described previously (15). 
The birds were challenged one day after the blood samples 
were taken. Each bird received 2000 £. multocida by intramuscular 
injection into the thigh. 
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RESULTS 
Skin test reactions 
Vaccinated turkeys developed a swelling at the site of injection 
24 hours after skin testing with reagent A (Table I). The swelling had 
the appearance of a small lump. The lump remained for at least five 
weeks. One nonvaccinated turkey developed a small lump. 
Four out of nine vaccinated turkeys developed a small white welt at 
the site of injection 24 hours after skin testing with reagent B. Each 
welt gradually disappeared over a ten-day period. None of the 
nonvaccinated turkeys showed any reaction. 
Granuloma formation 
Granulomas developed in all nine chickens injected with Freund's 
incomplete adjuvant plus M. tuberculosis (Table III). The granulomas 
were present for six weeks, the duration of the experiment. Some of 
the chickens that were injected with Freund's incomplete adjuvant 
plus 2" multocida developed a temporary thickening at the site of 
injection. However, this reaction was probably not a true granuloma 
because it disappeared within four weeks after the injection. The 
chickens that were injected with Freund's incomplete adjuvant showed no 
evidence of granuloma. 
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Drug induced immunosuppression 
Niridazole-treated vaccinated chickens had lower mortality than 
untreated vaccinated chickens (Table IV). The niridazole-treated 
chickens had a slightly enhanced agglutination titer. All of the 
chickens that were not vaccinated died from challenge exposure. 
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DISCUSSION 
Vaccinated turkeys developed a skin test reaction to both reagents. 
The reaction to reagent A (formalin inactivated £. multocida) appeared 
to be greater than the reaction to reagent B (formalin inactivated 
sonicated multocida). 
It was not possible to compare the results of the two different 
skin tests because the vaccination protocols and skin test reagent 
concentrations were dissimilar. Clearly, only limited conclusions can 
be drawn from the skin test experiments. Vaccinated turkeys appear to 
have the capacity to develop DTH-like skin test reactions under con­
ditions that are not well-defined. The author has attempted to elicit 
skin test reactions in £. multocida vaccinated chickens without success. 
There is no obvious explanation for this discrepancy. 
The decapsulated £, multocida incomplete adjuvant emulsion did not 
produce granulomas in chickens. Decapsulated cells were used because 
the capsule is believed to inhibit phagocytosis (16). The macrophages 
present in granulomas are highly phagocytic. The data indicate 
that decapsulated P^. multocida do not induce DTH reactions in 
chickens. 
Niridazole-treated vaccinated chickens had lower mortality and 
higher antibody titers than untreated vaccinated chickens. These 
data suggest two possibilities: (A) the niridazole was ineffective in 
producing suppression, or (B) the T lymphocyte functions suppressed by 
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niridazole are not required for challenge protection. 
The first alternative seems unlikely because previous reports have 
shown that the dosage used in these experiments was effective in 
inducing suppression in chickens (7,8). Niridazole treatment has been 
reported to enhance antibody response (7). In these experiments, the 
treated chickens had an elevated antibody titer as compared to the 
untreated chickens* The second alternative appears to be more reasonable. 
Suppression of T lymphocyte functions would not significantly affect 
mortality if they are not important in protection. If antibody 
mediated responses are important, then their potentiation could enhance 
protection. 
The results indicate that DTH is not a major component of 
protection in chickens. The skin test data indicate that there is a 
possibility that DTH might be elicited in vaccinated turkeys. 
Previous reports of cell-mediated irrenunity to multocida have 
all dealt with turkeys. It is possible that chickens respond differently 
to £. multocida vaccination than turkeys. 
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Table 1» Skin test reactions of JP, multocida vaccinated 
turkeys to whole cell preparation (Reagent A)® 
Vaccinated (n=4) 1 2 3 4 
Reaction^ 10 3 4 6 
Nonvaccinated (n=3) 1 2 3 
Reaction 0 2 0 
^Turkeys were skin tested with 10^ formalin killed 
Pc multocida two weeks after final vaccination. 
^Diameter of intradermal swelling in mm at 48 hours 
after skin testing. 
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Table 2. Skin test reactivity of P^. multocida vaccinated 
turkeys to sonicated preparation (Reagent B)9 
Vaccinated (n=9) 1 2 3 4 5 6 7 8 9 
Reaction^ 0 2 2 0 0 0 0 0 2 
Nonvaccinated (n=9) 1 2 3 4 5 6 7 8 9 
Reaction 0 0 0 0 0 0 0 0 0 
^Turkeys were skin tested with 0.1 cc of 10® 
sonicated P. multocida two weeks after final vaccination. 
^Diameter of intradermal swelling in mm at 48 hours 
after skin testing (9 turkeys). 
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Table 3. Presence of localized granuloma in injected chickens 
FIA® 0/9 FIA-PM^ 0/9 FIA-TB^ 9/9 
Ratios = Number of chickens with granuloma/number of chickens 
injected. 
These results were obtained five weeks after chickens were 
Injected. 
®1 ml of a 1:1, Freund's incomplete adjuvant:saline 
emulsion. 
^1 ml of a 1:1, Freund's incomplete adjuvant:saline 
emulsion containing 5 mg decapsulated killed P-1059 P^. multocida. 
^1 ml of a 1:1, Freund's incomplete adjuvant:saline emulsion 
containing 5 mg killed R37a: M. tuberculosis. 
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Table 4. Effect of niridazole treatment on immunity in chickens 
Vacc + ni rid® 1 2 3 4 5 6 
Titer'' 640 320 640 80 320 640 
Mortali ty^ + + 
Vacc alone^ 1 2 3 4 5 
Titer 640 40 160 40 160 
Mortality + + + + 
Control® 1 2 3 4 
Titer 0 0 0 5 
Mortality + + + + 
^Vaccinated and niridazole treated (n=6). 
^Titer: Agglutination end point expressed as reciprocal 
of dilution. 
^Mortality: Chickens dead from challenge infection +. 
^Vaccinated alone: No niridazole treatment (n=5). 
^Control: No vaccination. No niridazole (n=4). 
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PART V: TRANSFORMATION OF CHICKEN LYMPHOCYTES: OPTIMAL 
CULTURE CONDITIONS 
This paper will be submitted to 
Veterinary Immunology and Immunopathology for publication 
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SUMMARY 
The culture conditions for obtaining the maximum transformation 
of chicken lymphocytes are different from those of mammalian lymphocytes. 
Three differences were demonstrated: (A) the optimal cell concentration 
is much higher, (B) the optimal concentration of Concanavalin A is 
much higher, (C) ^H-thymidine should be added earlier. 
These results apply specifically to cells grown in microti ter 
tissue cultures. 
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The mitogen Concanavalin A is used extensively to study the 
activities of lymphocytes. Concanavalin A (Con A) induces T lymphocytes 
to undergo blast transformation (1). Mitogen stimulated T lymphocytes 
produce various lymphokines and factors that inhibit cell growth and are 
immunosuppressive (2). Many investigators have used mitogens to develop 
models of immunologic phenomena. Previous studies that have dealt with 
standardization of avian lymphocyte transformation assays have yielded 
variable results (3,4,5,6). 
The purpose of this report is to describe the culture conditions 
for obtaining the maximum transformation of chicken lymphocytes in 
microtiter tissue culture plates. These conditions are different from 
those of mammalian cultures. Three characteristic differences are 
described in this report: (a) the optimal cell number, (B) the optimal 
concentration of Con A, (C) the optimal time for addition of H-thymidine 
(^H-TdR). 
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MATERIALS AND METHODS 
Isolation of leukocytes 
Normal chickens aged 10 to 15 weeks were used. Blood was drawn 
by venepuncture and was collected into sodium citrate anticoagulant. 
One-fourth ml of 6% dextran was added to tubes containing 4 ml of 
blood. The tubes were centrifuged for 8 minutes at 80 x G and the 
buffy coat was removed by a Pasteur pipette. The buffy coat leukocytes 
were washed twice with RPMI-1640 medium by centrifugation.^ Viability 
was determined by the trypan blue dye exclusion test. Usually at 
least 95% of the cells were viable. Samples containing more than 5% 
erythrocytes were discarded. 
Cultures 
Leukocytes were cultured in Linbro 0.25 ml round bottom microti ter 
p 
tissue culture plates. RPMI-1640 tissue culture medium was supple­
mented with a 2 mMolar L-glutamine plus 100 units penicillin and 100 yg 
streptomycin per ml. Fetal bovine serum (10%) was added to the media 
in all the experiments with the exception of the experiment that was 
designed to evaluate serum requirements. The same lot of serum was 
used throughout the study. 
^Grand Island Biological Company, Grand Island, NY. 
^Linbro Scientific Inc., Hamden, CT. 
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Determination of serum requirement 
Two million leukocytes were cultured in media containing 4 mg 
Con A and 10% inactivated fetal bovine serum in each 0.25 ml microti ter 
culture.^ Controls consisted of cultures lacking either Con A or serum. 
All of the cultures were done in triplicate. The cultures were incubated 
at 41 C for 56 hours with 5% COg. Lymphocyte transformation was measured 
by adding 1 AjCi of ^H-methyl-thymidine (^H-TdR, specific activity 6.7 
O 
Ci/mM) 18 hours prior to termination. Cells were harvested with a 
Skatron cell harvester onto glass fiber filters and the radioactivity 
was counted in a beta scintillation counter. 
Determination of the optimal cell number 
Leukocytes were isolated from peripheral blood as described above. 
Cell concentrations varied from 5 x 10^ to 2.5 x 10® cells per culture in 
increments of 5 x 10^ cells. Each 0.25 ml well contained 4 mg Con A 
in RPMI-1640 media. All of the cultures were done in triplicate. The 
cultures were incubated at 41 C for 56 hours with 5% COg. Cells were 
O 
labeled with H-TdR as described above. 
Determination of the optimal mitogen concentration 
Two million leukocytes were cultured in each 0.25 ml culture well. 
The concentration of Con A was varied in increments of 2 yg from 0 yg 
^Con A, Sigma Chemical Co., St. Louis, MO. 
2 New England Nuclear, Boston, MA. 
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to 8 pg per culture. Cultures were incubated, labeled with ^H-TdR and 
harvested as described above. 
Determination of labeling kinetics 
Leukocytes were added to tissue culture wells as described 
above. Each culture contained 4 yg Con A. All of the cultures were 
done in triplicate. Serum and supplements were added as described 
above. 
O 
H-TdR incorporation was measured over four time intervals. 
Four microti ter plates were used for each experiment. The cultures 
were incubated at 41 C with 5% COg and labeled with ^H-TdR at different 
time intervals. The first plate was labeled for the initial 18 
hours of incubation and was then terminated by freezing. The second 
plate was labeled at the 18th hour of incubation and terminated at 
the 36th. The third plate was labeled at the 36th hour of incubation 
through the 54th hour and was then frozen. The final plate was labeled 
at the 54th hour and was terminated at the 72nd. Radioactivity was 
measured as described above. 
82 
RESULTS 
Serum requirements 
Serum was required for the proliferation of lymphocytes in Con A 
stimulated cultures. Cultures that lacked serum incorporated 
o 
approximately the same amount of H-TDR as cultures that lacked Con A 
(Fig. 1). The findings do not agree with those of Maheswaran et al. who 
obtained lymphocyte proliferation in the absence of serum (6). 
Optimal cell number 
O 
The greatest incorporation of H-TdR occurred when the cell number 
was adjusted to 2 x 10^ cells/culture well. When the cell number was 
reduced below this optimum, incorporation diminished significantly 
(Fig. 2). 
Optimal mitogen concentration 
3 The greatest incorporation of H-TdR occurred when the concentration 
of Con A was adjusted to 4 yg/culture well. Concentrations deviating 
from this optimum resulted in diminished incorporation (Fig. 3). 
Labeling kinetics 
Cultures that were labeled during the initial 18 hours of incubation 
o 
did not incorporate much H-TdR (Fig. 4). When cultures were labeled at 
the 18th through the 36th hour of incubation the most incorporation 
occurred. Incorporation diminished slightly when cultures were labeled 
after the 36th hour. 
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Appearance of cultures 
All experiments were monitored by observation with an inverted 
tissue culture microscope. In all cases the development of focal 
O 
areas of proliferation correlated with the incorporation of H-TdR. 
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DISCUSSION 
The results demonstrate that the culture conditions for obtaining 
the maximum transformation of chicken lymphocytes are different from 
those of mammals. Three fundamental differences were demonstrated: 
(A) the optimal cell concentration is much higher, (B) the optimal 
concentration of Con A is higher, (C) ^H-TdR should be added earlier. 
In humans, mice, cows, rats, and pigs, the cell number is 
usually adjusted to within 2 x 10^ to 4 x 10^ cells/microtiter culture 
(7,8,9,10). For chickens, the optimum is 2 x 10^ cells/microtiter 
culture. When leukocytes are isolated from chicken spleens by ficoll 
gradient centrifugation, a similar number of cells are required to 
produce optimum transformation (unpublished observations). The results 
obtained in this study agree with the results of Meyers et al. who 
showed that 2 x 10® cells/microtiter culture was optimum for obtaining 
transformation of chicken lymphocytes stimulated by phytohemagglutinin 
(11).  
In this system the optimal concentration of Con A was found to be 
4 yg/microtiter culture (20 yg/ml). When human lymphocytes are 
cultured, Con A is used at a concentration of 1 yg/microtiter culture 
(5 yg/ml), or less (7). It is not apparent why these differences exist. 
Chicken lymphocytes proliferated very rapidly. The maximum 
incorporation of H-TdR occurred between 18 and 36 hours of incubation. 
A study of chicken cells in macroculture yielded similar results (4). 
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Most lymphocyte transformation assay protocols for mammals specify that 
the cells should be labeled only after a minimum of 50 hours of incubation 
have elapsed. Clearly, this would not be the optimal time to label 
chicken cultures. The unusually rapid proliferation was probably not 
caused by the 41 C incubation temperature. Cultures incubated at 37 C 
showed similar proliferation rates. 
These results demonstrate that chicken leukocyte cultures respond 
differently to Con A than cultures of mammalian origin. These 
observations are important because when chicken cells are used, the 
assay should be modified accordingly. 
These findings also apply to chicken leukocytes cultured with 
antigen. The maximum transformation produced by stimulation with the 
purified protein derivative of Mycobacterium tuberculosis was obtained 
with a 2 X 10^ cells/microtiter culture (unpublished observations). 
o 
The optimum incorporation of H-TdR occurred between 18 and 36 hours 
of incubation. 
Figure 1. Serum requirement 
Typical response pattern of Con A stimulated 
chicken lymphocytes cultured in the presence 
or absence of 10% fetal bovine serum. 
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Figure 2. Optimal cell number 
Typical response pattern of varying numbers of 
Con A stimulated buffy coat leukocytes. 
Typical pattern of varying numbers of 
unstimulated buffy coat leukocytes. 
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Figure 3. Optimal concentration of Con A 
Typical response pattern of buffy coat 
leukocytes stimulated by different 
concentrations of Con A. 
Individual responses of leukocytes from 
4 chickens are shown. 
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Figure 4. Labeling kinetics 
Typical response of buffy coat leukocytes 
labeled with ^H-TdR at different time 
intervals. 
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PART VI: STUDIES OF CELL-MEDIATED IMMUNITY TO 
PASTEURELLA MULTOCIDA: A COMPARISON 
TO MYCOBACTERIUM TUBERCULOSIS 
The immune response induced by Pasteurella multocida vaccination 
was compared to the response induced by Mycobacterium tuberculosis 
vaccination. Two in vitro correlates of cell-mediated immunity, 
the lymphocyte transformation test, and the leukocyte migration 
inhibition test, were used. M. tuberculosis was shown to induce an 
intense cell-mediated response whereas IP. multocida evoked at most 
only a very minimal cell-mediated response. 
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INTRODUCTION 
The itimune response to Pasteurella multocida vaccination is not 
well-understood. Vaccination can induce significant levels of circu­
lating antibody, yet it is not clear to what extent cell-mediated 
immunity is induced. Some studies have indicated that turkeys 
vaccinated with P^. multocida bacterins may develop cell-mediated 
immunity (1,2,3). In contrast, the immunity to Mycobacterium tuberculosis 
has been much more thoroughly studied (4). When either live or dead 
M. tuberculosis are inoculated into an animal, a very strong cellular 
response occurs (5). 
The purpose of this study was to determine whether K multocida 
vaccinated chickens developed: (A) cell-mediated immune responses to 
iP. multocida antigens and (B) a cellular response similar in magnitude 
to Mycobacterium tuberculosis vaccinated chickens. 
Two methods were used to assay for cell-mediated immunity: 
(A) the lymphocyte transformation test and (B) the leukocyte migration 
inhibition test. Both assays can be used to measure in vitro correlates 
of cell-mediated immunity (6,7). 
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MATERIALS AND METHODS 
Preparation of f « "lultocida antigens 
Two JP. miiltocida test antigens were prepared. Antigen A consisted 
of a sonicate soluble fraction of P^. multocida. Strain 1059 was grown 
on tryptose agar in Roux bottles for 18 hours at 37 C. The bacteria 
were removed from the agar surfaces with sterile saline. Cells were 
washed and centrifuged twice with sterile saline. The suspension was 
placed in a sonic oscillator chamber and sonicated with a 250 watt 
10 kc generator for 7 minutes. A sample of the suspension was plated 
on tryptose agar to check for contaminants. The sonicated multocida 
were then centrifuged at 21,000 x G for 15 minutes in a Sorvall RC2-B 
refrigerated centrifuge.^ A dense pellet and clear supernatant fluid 
remained. The supernatant fluid was drawn off by a Pasteur pipette and 
was lyophilized. 
Antigen B consisted of a heat stable capsular extract of £. 
multocida. Strain P-1059 was harvested from tryptose agar with sterile 
saline. A sample of the suspension was plated on tryptose agar to check 
for contaminants. The suspension was heated at 56 C for 30 minutes. The 
heat treated £. multocida were centrifuged at 21,000 x G and the 
supernatant was used as antigen. The supernatant was frozen prior to 
storage. Both antigens reacted against antiserum to £. multocida 
in gel diffusion tests. 
^Ivan Sorvall Inc., Newtown, CT. 
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Vaccination of chickens 
Killed 2' multocida strain P-1059 was emulsified in Freund's 
q 
complete adjuvant. The bacterin contained 10 cells/ml. Chickens, 
aged 9 to 12 weeks were vaccinated with 1 ml of the bacterin three 
times at three-week intervals. 
An additional group of chickens was vaccinated with M. tuberculosis. 
Killed M. tuberculosis strain R37a was emulsified in Freund's complete 
adjuvant. Each chicken received a single subcutaneous injection of 10 
mg M. tuberculosis in one ml of emulsified adjuvant. 
Blood and spleen samples were taken from birds four to eight weeks 
after vaccination. 
Preparation of peripheral blood leukocytes for the transformation test 
Blood was drawn by venepuncture and collected into sodium citrate 
anticoagulant. One-fourth ml of 6% dextran was added to tubes containing 
4 ml of blood. The tubes were centrifuged at low speed for 8 minutes 
at 80 X G and the buffy coat was removed by aspiration with a Pasteur 
pipette. The buffy coat leukocytes were washed twice with RPMI-1640 
media by centrifugation.^ Viability was determined by the trypan blue 
dye exclusion test. Usually, at least 95% of the cells were viable. 
Samples containing more than 5% erythrocytes were discarded. Leukocyte 
concentrations were adjusted so that 2 x 10® cells were incubated in 
^Grand Island Biological Co., Grand Island, NY. 
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each 0.25 ml round bottom well of a microti ter tissue culture plate. 
Heat inactivated fetal bovine sera (10%) was added to the cultures; 
the same lot of serum was used in each experiment. Media was supple­
mented with 2 mMolar L-glutamine plus 100 units penicillin and 100 
Vig of streptomycin per ml. 
Isolation of leukocytes from spleens 
Spleens were removed from IP- multocida vaccinated chickens. The 
capsular material surrounding the spleen was discarded. Each spleen 
was minced in RPMI-1640 medium. The minced suspension was centrifuged 
at low speed to remove large clumps of tissue. The spleen suspension 
was layered over ficoll-pague and centrifuged to isolate leukocytes. 
The leukocytes were drawn off from the interface with a Pasteur pipette. 
The cells were washed and cultured in microti ter plates as described 
above. 
Lymphocyte transformation test 
£. multocida antigens were added to leukocyte cultures prior to 
incubation. Sonicate soluble fraction was used at a concentration of 
100 yg/culture, as described by Maheswaran et al. (1). Capsular extract 
was used at a concentration of 6 yg/culture. The extract was found 
to produce optimal stimulation at this concentration. Capsular protein 
was estimated by the method of Lowry et al. (8). 
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Mycobacterial antigen (purified protein derivative of M. 
tuberculosis, without preservative) was used at a concentration of 
either 50 yg/culture or 25 yg/cultureJ Cell cultures were labeled 
with ^H-methyl thymidine (^H-TdR, sp. act. 6.7 Ci/mmole), at either 
2 
zero hours, 18 hours, or 36 hours of incubation. Cultures were 
terminated by freezing 18 hours after labeling. Cells were harvested 
with a Skatron cell harvester onto glass fiber filters and the radio­
activity was counted in a beta scintillation counter. The stimulation 
index was calculated by the formula: 
stimulation index (SI) = z::::i::: i::s%3iagen 
Leukocyte migration inhibition test 
Leukocytes were isolated from peripheral blood as described above. 
Capillary tubes (75 mm without heparin) were filled with the leukocyte 
O 
suspension. One end of each capillary tube was closed with capillary 
tube sealant. Tubes were centrifuged for 5 minutes or until the 
leukocytes were tightly packed at the bottom of each capillary tube. 
The capillary tubes were cut just below the cell boundary and then 
^Parke-Davis Tuberculin PPD, Detroit, MI. 
p 
New England Nuclear, Boston, MA. 
^Fisher Scientific, Pittsburgh, PA. 
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anchored to the bottom of tissue culture plates with sterile stopcock 
grease. Two migration inhibition antigens were prepared: (A) sonicate 
soluble fraction was added to RPMI-1640 medium (500 yg/ml) containing 
10% fetal bovine sera; (B) heat-killed P.. multoeida (10^ cells/ml) were 
added to RPMI-1640 containing 10% fetal bovine sera. One ml of media 
supplemented with antigen was added to tissue culture wells that 
contained capillary tubes. Three sets of control cultures were made: 
(A) sensitized leukocytes without antigen, (B) unsensitized leukocytes 
with antigen, and (C) unsensitized leukocytes without antigen. The 
cultures were incubated for 4 hours at 37 C. Cell migration was 
magnified lOX with a microscope slide projector. Migration distance was 
measured with a ruler. The percentage of migration-inhibition was 
calculated with the following formula. 
Percentage migration inhibition = , .0 - ::: :i:L:r:Sgen 
X 100 
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Optimal culture conditions for obtaining maximum proliferative response 
to P. multocida and M. tuberculosis antigens 
The number of cells in culture was a critical factor in trans­
formation assays. It was advantageous to use 2 x 10® rather than 10® 
leukocytes per culture. Cultures that contained 2 x 10® cells 
incorporated the greatest amount of H-TdR (Fig. 1). These results 
agree with the observations by Meyers et al. (9). 
Cell cultures that were labeled between 18 and 39 hours of incubation 
3 incorporated more H-TdR than cultures labeled at other time intervals 
(Figs. 2,3). Cellular proliferation was greatest during this period. 
Lymphocyte transformation: response to P.. multocida antigens 
Leukocytes from vaccinated chickens had slightly higher stimulation 
indices than did leukocytes from nonvaccinated chickens (Fig. 4). 
Peripheral blood leukocytes and spleen leukocytes responded similarly. 
Capsular material and sonicate soluble fraction induced similar 
responses (Fig. 5). 
Lymphocyte transformation: response to purified protein derivative of 
M. tuberculosis 
Peripheral blood leukocytes from M. tuberculosis vaccinated chickens 
had much higher stimulation indices than did nonvaccinated chickens 
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(Fig. 6). A concentration of 50 yg purified protein derivative (PPD) 
per culture produced greater responses than 25 yg. Leukocytes from M. 
tuberculosis vaccinated chickens had much higher stimulation indices 
than did leukocytes obtained from multocida vaccinated chickens 
(Figs. 4,5,6). 
Migration inhibition test: response to £. jnultocida antigens 
Significant levels of leukocyte migration inhibition were not 
demonstrated. Generally, over 30% inhibition must exist before the 
presence of migration inhibition factor can be assumed (10). When cells 
from vaccinated chickens were cultured with sonicate soluble fraction, 
inhibition was 0.14 + .08. Cells from nonvaccinated chickens had an 
average inhibition of 0.08 + .10 (Fig. 7). It was not clear why 
leukocytes from nonvaccinated chickens showed some migration inhibition. 
In a similar experiment in which leukocytes from vaccinated 
turkeys were incubated with heat killed £. multocida, significant 
levels of leukocyte migration inhibition were not demonstrated (Fig. 8). 
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DISCUSSION 
Antigen stimulated microti ter cultures that contained 2 x 10® 
leukocytes incorporated more H-TdR than did microti ter cultures containing 
10® leukocytes (Fig. 1). Mammalian systems require between 2 x 10® 
and 5 x 10® cells per microti ter culture. The results agree with the 
findings of Maheswaran and Thies (11), and Meyers et al. (9). 
Antigen stimulated microtiter cultures that were labeled between 
the 18th and 39th hour of incubation incorporated ^H-TdR (Figs. 2,3). 
These data agree with the finding of Aim, who observed that mitogen 
3 stimulated lymphocytes incorporated the greatest amount of H-TdR 
during this period (12). 
Leukocytes from 2- multocida vaccinated chickens had slightly 
higher stimulation indices than did leukocytes from nonvaccinated 
chickens (Figs. 4,5). In contrast, leukocytes from M. tuberculosis 
vaccinated chickens had much higher stimulation indices than did non-
vaccinated chickens (Fig. 6). Several factors might account for this 
difference: (A) M. tuberculosis may act as a more potent activator of 
cell-mediated immunity as compared to P^. multocida, (B) the P^. multocida 
antigens used in the lymphocyte transformation and leukocyte migration 
inhibition tests were highly heterogeneous, whereas the M. tuberculosis 
antigen (PPD) was highly purified. Inhibitory substances may have been 
present in the P^. multocida sonicate soluble fraction and the capsular 
material, (C) the £. multocida vaccination protocol might have favored the 
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production of suppressor T cells. 
Some consideration should be directed toward a greater understanding 
of the multocida fractions used in this study. The sonicate soluble 
fraction and capsular material have not been well-characterized. 
Previous studies have demonstrated the extensive heterogeneity of 
antigens in various £. multocida extracts (13). It is possible that 
sonicate soluble fraction and capsular material possess similar antigens 
and may actually be similar or contain identical substances. 
A number of other procedures have been used to obtain P^. multocida 
antigens. These procedures include phenol, trichloroacetic acid, and 
potassium thiocyanate extractions (14,15,16). In a study of various 
extracts, Maheswaran found that a sonicate soluble fraction of 
multocida induced the greatest lymphocyte transformation response (1). 
Before in vitro correlates of cell-mediated imunity can be 
accurately evaluated, the various P^. multocida antigens will have to 
be more adequately and thoroughly characterized. 
Figure 1. Optimal cell number 
Response pattern of various numbers of 
leukocytes to stimulation with £» multocida 
sonicate soluble fraction. 
nv=nonvaccinated chicken, 
Vi=2. multocida vaccinated chicken #1. 
V2=Po multocida vaccinated chicken #2. 
Results expressed as stimulation index + S^D. 
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Figure 2. Kinetics of proliferative response 
to multocida sonicate soluble 
fraction 
nv=nonvaccinated chicken. 
Vi=_P. multocida vaccinated chicken #1. 
V2=£. multocida vaccinated chicken #2. 
Results expressed as stimulation index S.C. 
STIMULATION INDEX 
M CO ^ ai o> 
Figure 3. Kinetics of proliferative response to 
purified protein derivative of M. tuberculosis 
nv=nonvaccinated chicken. 
vi=M. tuberculosis vaccinated chicken #1. 
V2=M. tuberculosis vaccinated chicken #2. 
Results expressed as stimulation index + S.D. 
STIMULATION INDEX 
Figure 4. Proliferative response to sonicate soluble 
fraction of P^. multocida: Comparison of the 
response of leukocytes isolated from the blood 
and spleen 
vacc=£. multocida vaccinated. 
not vacc=not vaccinated. 
There were four chickens tested (n=4) in each 
group. 
Results expressed as stimulation index + S.D. 
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I 
5-
vacc 
BLOOD SPLEEN 
Figure 5. Proliferative response to capsular material 
of 2" multocida 
vacc=£. multocida vaccinated. 
not vacc=not vaccinated. 
There were three chickens tested (n=3) in 
each group. 
Results expressed as stimulation index + S.D. 
STIMULATION INDEX 
CO U1 
Figure 6. Proliferative response to purified protein 
derivative of M. tuberculosis 
vacc=M. tuberculosis vaccinated. 
not vacc=not vaccinated. 
There were four chickens tested (n=4) in each group. 
Results expressed as stimulation index + S.D. 
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Figure 7. Leukocyte migration inhibition test: 
sonicate soluble fraction was used as 
antigen 
vacc=£. multocida vaccinated, 
not vacc-not vaccinated. 
There were six chickens tested (n=6) in 
each group. 
Results expressed as percent migration 
inhibition + S.D. 
P E R C E N T  M I G R A T I O N  I N H I B I T I O N  
I ro 00 
o» o o o o 
Figure 8. Leukocyte migration inhibition test 
(turkey) 
Heat killed bacteria (10^/ml) were used 
as antigen. 
vacc=£. multocida vaccinated, 
not vacc=not vaccinated. 
There were six turkeys tested (n=6) in 
each group. 
Results expressed as percent migration 
inhibition + S.D. 
PERCENT MIGRATION INHIBITION 
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SUMMARY AND CONCLUSIONS 
This dissertation consists of a series of five papers that deal 
with the immune response produced by Pasteurella multocida vaccination. 
A sixth paper (Section V) describes a study designed to find the optimal 
culture conditions for growing chicken lymphocytes. The study was a 
necessary prerequisite to the in vitro studies reported in Section VI. 
The objective of this research was to determine the extent that humoral 
and cell-mediated responses are elicited by vaccination. The experiments 
were designed to evaluate: (A) the protective role of antibody response, 
(B) whether in vitro and in vivo correlates of cell-mediated immunity 
can be demonstrated, and (C) whether cell-mediated responses to P^. 
multocida are of similar magnitude as responses to M. tuberculosis 
vaccination. 
Summary of results 
A single vaccination with a formalin inactivated P^. multocida 
bacterin produced significant antibody titers in chickens and turkeys. 
Revaccination produced four-fold increases in titers. The bacterin was 
capable of inducing a significant level of immunity as demonstrated by 
resistance to challenge (Section I). Passive protection studies 
indicated that antiserum was capable of inducing temporary protection. 
Antibody titers appeared to correlate with protection (Section II). 
Newly hatched chickens were treated with cyclophosphamide for a 
period of four days and later vaccinated (Section III). The treatment was 
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designed to suppress antibody production but leave cell-mediated immunity 
intact. Chickens treated in this manner were very susceptible to challenge 
infection. Vaccinated bursectomized turkeys were also susceptible to 
challenge infection (Section II). If cell-mediated immunity were a 
major component of protection, it seems likely that groups of vaccinated 
cyclophosphamide treated birds, and groups of vaccinated bursectomized 
birds, would not be expected to have appreciable mortality following 
challenge infection. However, mortality was very high, which suggests 
that cell-mediated responses may not be as important as antibody response. 
The results indicated that there is a correlation between the presence 
of agglutinating antibody and resistance to challenge infection. 
In vivo tests did not clearly indicate the presence of delayed 
hypersensitivity to multocida (Section IV). Chickens that were 
injected with decapsulated £. multocida in Freund's incomplete adjuvant 
did not develop granulomatous lesions indicative of delayed hyper­
sensitivity. In contrast, chickens that were injected with killed M. 
tuberculosis in Freund's adjuvant developed intense granulomatous lesions 
that lasted in excess of ten weeks (Appendix). 
JP. multocida vaccinated chickens did not develop skin test reactions 
(Section IV). In contrast, a small group of turkeys tested under similar 
conditions developed skin test reactions that may have been representative 
of delayed hypersensitivity. Vaccinated chickens that were fed niridazole, 
a T cell immunosuppressant, did not show increased challenge mortality. 
This finding suggests that cell-mediated response is not a major factor 
in protection (Section IV). However, it was not confirmed that the 
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niridazole produced immunosuppression, so this particular experiment 
must be interpreted with caution. 
Lymphocytes from vaccinated chickens underwent blast transformation 
after exposure to P^. multocida antigens (Section VI). Stimulation 
indices rarely exceeded five. When lymphocytes from M. tuberculosis 
vaccinated chickens were incubated in the presence of PPD of M. 
tuberculosis, stimulation indices in excess of 20 were recorded. M. 
tuberculosis appears to act as a much more potent activator of cell-
mediated responses than does P^. multocida. The leukocyte migration 
inhibition test, an established in vitro correlate of cell-mediated 
immunity, failed to indicate that £. multocida vaccination induced 
delayed type hypersensitivity (Section VI). 
The lymphocyte transformation response was minimal. This response, 
in itself, does not necessarily indicate that cell-mediated immunity is 
the primary means of protection. In addition, it is unclear which 
population of lymphocytes (T or B) were actually proliferating in response 
to the £. multocida antigens. However, a role for T lymphocytes cannot be 
excluded. T lymphocytes may act as helper cells in antibody formation. 
Significance of this work 
The results of this research are significant for two reasons: (A) 
they may facilitate the further development of more effective vaccines, 
and (B) they further our understanding of the immune response to £. 
multocida. 
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The results demonstrate that in poultry the protective immune 
response that is induced by P^. multocida adjuvant bacterins is 
primarily antibody mediated. In contrast, cell-mediated responses do 
not appear to be as important. It is apparent that P^. multocida 
vaccines should be produced and administered so as to induce a prolonged 
antibody response. The selection of adjuvant and immunizing schedules 
should be adjusted so that continuous antigen stimulation is provided. 
The results also demonstrate that the immunity induced by 
multocida vaccination is similar to that induced by vaccination with other 
Gram negative non-intracellular bacteria because the immunity is primarily 
antibody mediated. Previous studies, particularly those by Baba, and 
others by Dua and Maheswaran, indicated that P^. multocida vaccination 
might be an exception and might induce a strong cell-mediated response 
(30,9). This discrepancy appears to have been resolved. The studies 
reported here suggest that while cell-mediated responses may exist, they 
probably play only a minor role in protective immunity. Cell-mediated 
immunity is usually demonstrated against intracellular organisms, in­
cluding certain bacteria, parasites, fungi, and most viruses. Clearly, 
this is not the case with £. multocida. There is no evidence suggesting 
that multocida is an obligate intracellular pathogen. 
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Inactivated vaccine vs live vaccine 
In all of the experiments in this study, a formalin inactivated 
multocida bacterin was used for vaccination. It is essential to 
recognize that an inactivated bacterin may induce the formation of 
immune responses substantially different from a live vaccine. However, 
previous studies have shown that IP. multocida adjuvanted bacterins induce 
the most substantial and lasting immunity (9). Maheswaran has reported 
that turkeys vaccinated with a P. multocida adjuvanted bacterin produced 
a stronger cell-mediated immune response than turkeys vaccinated with a 
live vaccine administered in drinking water (9). 
The use of inactivated vaccines does not necessarily preclude the 
development of cell-mediated immune responses. It has been known for 
many years that Freund's complete adjuvant (incomplete adjuvant plus 
killed Mycobacteria) induces a state of cellular immunity. Similarly, 
dinitrophenyl-bovine gamma globulin and a series of a, N-dinitrophenyl-
L-lysines have been shown to activate cell-mediated immune responses 
(44,57). 
Activated macrophages play an important role in cell-mediated 
immunity. Materials that induce macrophage activation are often capable of 
producing cell-mediated immunity. It has not been demonstrated that P^. 
multocida can induce macrophage activation. Some studies have shown 
that phagocytized Pasteurellae produce the opposite effect: £. hemolytica 
are cytocidal for neutrophils and macrophages (61,62). 
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The following conclusions can be made from this study: 
(A) Vaccination with a formalin-inactivated adjuvant bacterin 
provides a significant level of protective immunity. 
(B) Vaccination produces detectable levels of antibody in 
chickens and turkeys. 
(C) The antibody produced by vaccination is protective. 
(D) Various indicators of cell-mediated immunity suggest that 
cell-mediated immunity is probably only a minor component 
of protection to £. multocida challenge. 
(E) The immunity produced by P^. multocida vaccination is 
different from the immunity produced by M. tuberculosis 
vaccination. 
Some areas for further study can be clearly identified: 
(A) The immune response to purified homogenous antigens should 
be investigated. K multocida possesses a wide spectrum of 
antigens. A study should be initiated to determine which 
antigens are involved in inducing protection, and how they 
induce protection. The capsular and sonicate soluble fraction 
used in this study was very heterogeneous and could have 
possessed substances which interfered with in vitro and in 
vivo tests for cell-mediated immunity. 
(B) Live attenuated £. multocida vaccines must be further perfected. 
The recent development of the MSG £. multocida vaccine in 
Israel is an important step (63). The MSG vaccine appears to 
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be safer and offer more protection than the CIemson strain. 
The Immunity induced by this vaccine should be studied in 
order to determine the importance of humoral and cellular 
response in protection. 
(C) It is not known why turkeys are more susceptible than chickens 
to challenge infection. There may be inherent differences in 
the immunologic capabilities of chickens and turkeys. 
(D) Cross-protection needs to be more thoroughly understood 
(see the second article in this series for discussion). Cross-
protection is observed after a £. multocida bacterin has been 
grown in vivo and is not observed after growth in vitro. This 
phenomenon is important in the development of vaccines that 
provide protective immunity against different serotypes of P^. 
multocida. 
This project has been interesting and productive. The results should 
be useful in the further development of riiultocida vaccines. 
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APPENDIX 
Figure 1. Reaction of tnuUocida capsular material 
material (2) and P^. multocida sonicate soluble 
fraction (3) against antisera obtained from a 
P. multocida vaccinated chicken (1) 
Figure 2. Buffy coat leukocytes isolated from turkey 
blood by dextran sedimentation. Wrights 
stain. Magnification 400 X 
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Figure 3. Histologic appearance of granulomatous 
lesion from chicken inoculated with 
inactivated M. tuberculosis. Intense 
mononuclear infiltrate is present. 
H ànd E stain. Magnification 400 X 
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